ICE
66
2
NAVI
41
-2
UNM
65
2
AA
48
-3
TRV
56
4
HAL
41
-2
FSLR
47
-20
OMC
65
23
CSCO
73
-9
TRIP
58
-3
HPE
66
9
AES
49
-6
NI
78
3
ZBH
48
-6
BIIB
50
5
XRX
49
-3
AFL
42
-3
SYF
81
-2
XOM
45
-5
JBHT
33
-2
ICE
66
2
NAVI
41
-2
UNM
65
2
AA
48
-3
TRV
56
4
HAL
41
-2
FSLR
47
-20
OMC
65
23
CSCO
73
-9
TRIP
58
-3
HPE
66
9
AES
49
-6
NI
78
3
ZBH
48
-6
BIIB
50
5
XRX
49
-3
AFL
42
-3
SYF
81
-2
XOM
45
-5
JBHT
33
-2
Financhill
Back

ProShares Ultra Nasdaq Biotechnology Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
44

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
$44.00
Seasonality Move:
8.32%

7 Day Trial

ALL ACCESS PASS

$ 7

ProShares Ultra Nasdaq Biotechnology Stock Forecast

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 23% based on the past 15 years of stock performance.
  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is ProShares Ultra Nasdaq Biotechnology Stock Undervalued?
    The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $43.95. The Score for BIB is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will ProShares Ultra Nasdaq Biotechnology Stock Go Up Next Year?

  • Over the next 52 weeks, ProShares Ultra Nasdaq Biotechnology has on average historically risen by 23% based on the past 15 years of stock performance.

ProShares Ultra Nasdaq Biotechnology Stock Rating

Sell
44
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology overpriced?

  • ProShares Ultra Nasdaq Biotechnology has risen higher in 10 of those 15 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

ProShares Ultra Nasdaq Biotechnology Stock Price History

Is BIB stock going to rise?

  • The current trend is relatively stagnant and BIB is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
69.56
52-Week Low:
33.78

Prediction Charts

Market Cap:
0
Price in USD:
43.95
Volume:
3.2K
Beta:
1.83

Technical Analysis

SMA50:
45.92
SMA100:
49.78
SMA200:
56.05
52-Wk Change:
-22.96%

Stock Predictions

  • Is ProShares Ultra Nasdaq Biotechnology stock public?
    Yes, ProShares Ultra Nasdaq Biotechnology is a publicly traded company.
  • What is the ProShares Ultra Nasdaq Biotechnology stock quote today?
    The ProShares Ultra Nasdaq Biotechnology stock price is 43.95 USD today.
  • How to buy ProShares Ultra Nasdaq Biotechnology stock online?
    You can buy ProShares Ultra Nasdaq Biotechnology shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-30 46.58 47.46 47.46 45.70
May-1 46.75 46.31 47.14 46.22
May-2 47.87 47.58 47.96 47.48
May-5 47.54 46.91 47.54 46.74
May-6 45.32 41.26 45.63 41.21
May-7 41.33 41.56 41.75 40.81
May-8 40.63 41.24 41.88 39.47
May-9 41.00 39.63 42.23 39.63
May-12 40.09 43.10 43.42 40.09
May-13 42.01 41.48 42.01 41.05
May-14 41.66 39.84 41.66 39.56
May-15 39.85 41.61 41.61 39.75
May-16 41.61 42.96 42.96 41.48
May-19 42.91 43.95 43.95 42.91

ProShares Ultra Nasdaq Biotechnology Earnings

Data Unavailable

ProShares Ultra Nasdaq Biotechnology Forecast Revenue Growth

Data Unavailable

* ProShares Ultra Nasdaq Biotechnology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.